Genomic and Precision Medicine (3rd Ed.)
Cardiovascular Disease

Coordinators: Ginsburg Geoffrey S., Willard Huntington F

Language: English
Cover of the book Genomic and Precision Medicine

Subject for Genomic and Precision Medicine

Keywords

Acute coronary syndrome (ACS); Adverse responders; Allele; Anticoagulant; Antiplatelet; Antithrombotic; Apolipoprotein; Atherosclerosis; Atrial fibrillation; Beta-myosin heavy chain (MYH7); Biomarkers; Birth defect; Cardiovascular disease; Cardiovascular traits; Cholesterol; Chylomicron; Congenital heart disease; Continuous blood pressure variation; Coronary artery disease; Coronary heart disease; Disease pathology; Dyslipidemia; Echocardiography; Exceptional responders; Exercise; Familial aggregation; Family health history; GWAS; Gene association studies; Gene expression; Gene polymorphism; Gene therapy; Genetic polymorphisms; Genetic testing; Genetic variation; Genetics; Genome wide association studies; Genome-wide association; Genome-wide association studies; Genome-wide association study; Genomewide association study; Genomic methodology; Genomics; Haplotype; Heart failure; Heritability; High-density lipoprotein; Host response; Hypertension; Hypertrophic cardiomyopathy (HCM); Hypertrophy; Insulin resistance; Ion channels; Ischemic stroke; Left ventricular hypertrophy (LVH); Linkage disequilibrium; Lipoprotein; Long-QT syndrome; Low-density lipoprotein; Management; Mendelian; Metabolic syndrome; Modifier gene; Monogenic; Musculoskeletal; Mutation; Myocardial infarction; Myofilament; Myosin binding protein C (MYBPC3); Next-generation sequencing; Obesity; Organ injury; Patient-entered data; Peripheral arterial disease; Personalized medicine; Pharmacodynamics; Pharmacogenetic; Pharmacogenetics; Pharmacogenomics; Pharmacokinetic; Polymorphism; Precision medicine; Prevention; Proarrhythmia; Proteomics; Quantitative trait locus; Review; Risk assessment; Risk genes; Risk prediction; Risk profiling; Sarcomere; Single nucleotide polymorphism; Sudden cardiac death; Sudden cardiac death (SCD); Surgery; Systems medicine; Therapeutic angiogenesis; Torsades de pointes; Triglycerides

118.07 €

In Print (Delivery period: 14 days).

Add to cartAdd to cart
Publication date:
Support: Print on demand

Genomic and Precision Medicine: Cardiovascular Disease, Third Edition, focuses on the applications of genome discovery on the broad spectrum of cardiovascular disorders. Each chapter is organized for the application of genomics and personalized medicine tools and technologies to a) Risk Assessment and Susceptibility, b) Diagnosis and Prognosis, c) Pharmacogenomics and Precision Therapeutics, and d) Emerging and Future Opportunities in the field.

1. Overview: A Systems Approach To Cardiovascular Medicine
2. Application of Human Genome Information to Clinical Practice
3. Translating genome information into clinical practice and human health
4. Big Data and Translational Bioinformatics Genomic and Personalized Medicine
5. Health Risk Assessment and Family History
6. Clinical Decision Support
7. Overview of Policy, Ethical and Social Considerations
8. Hypertension
9. Lipoprotein Disorders
10. Coronary Artery Disease and Myocardial Infarction
11. The Vulnerable Plaque and Acute Coronary Syndromes
12. Heart Failure
13. Hypertrophic Cardiomyopathies
14. Arrhythmias
15. Hemostasis and Thrombosis
16. Peripheral Arterial Disease
17. Congenital Heart Disease
18. Perioperative Genomics
19. Stroke
20. Novel Approaches to Cardiovascular Diagnostics
21. Cardiovascular Pharmacogenomics
22. Case Studies
Medical students, life sciences and engineering graduate students, advanced undergraduate students, and residents and fellows working with any aspect of genomic research in the life sciences and/or medicine; educators, and translational scientists.
Dr. Ginsburg is the founding Director of the Center for Applied Genomics & Precision Medicine in the Duke Institute for Genome Sciences & Policy. He is also Professor of Medicine and of Pathology at Duke University Medical Center, Professor of Biomedical Engineering at Duke Pratt School of Engineering, and Co-Director of the Duke Translational Medicine Institute.
Huntington Willard is on the faculty of the Department of Human Genetics at the University of Chicago. Prior to this appointment, Willard was the President and Director of the Marine Biological Laboratory and Professor of Human Genetics at the University of Chicago. He was previously on the faculty at Duke University, where he was founding director of the university-wide Duke Institute for Genome Sciences & Policy from 2003 to 2014, the Nanaline H. Duke Professor of Genome Sciences, and the Arts & Sciences Professor of Biology & Genome Sciences.
  • Presents a comprehensive volume written and edited by cardiovascular genomic specialists
  • Covers succinct commentary and key learning points that will assist providers with their local needs for the implementation of genomic and personalized medicine into practice
  • Provides an overview on major opportunities for genomic and personalized medicine in practice
  • Includes case studies that highlight the practical use of genomics in the management of patients